3-[(3R)-oxan-3-yl]propanoic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧烷类
• 英文名称: 3-[(3R)-oxan-3-yl]propanoic acid
• 化学式: C₈H₁₄O₃
• 分子量: 158.19
• InChiKey: RWPBWJMWHVFSEN-SSDOTTSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• PROCESSES FOR PREPARING DIHYDROPYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF
  申请人：SUNSHINE LAKE PHARMA CO., LTD.

  公开号：US20160244438A1

  公开（公告）日：2016-08-25

  The present invention relates to processes for preparing a dihydropyrimidine derivative having Formula (I) or a tautomer thereof having Formula (Ia), as well as a intermediate thereof. The processes of the invention have simple operation, high optical purity of product, high yield and convenient work-up, which is suitable for industrial production.

  本发明涉及制备具有式(I)的二氢嘧啶衍生物或具有式(Ia)的其互变异构体以及其中间体的方法。本发明的方法操作简单，产物的光学纯度高，收率高且操作方便，适合于工业生产。
• DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS
  申请人：SUNSHINE LAKE PHARMA CO., LTD.

  公开号：US20160347746A1

  公开（公告）日：2016-12-01

  Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases.
• US9617252B2
  申请人：——

  公开号：US9617252B2

  公开（公告）日：2017-04-11
• US9573941B2
  申请人：——

  公开号：US9573941B2

  公开（公告）日：2017-02-21
• US9643962B2
  申请人：——

  公开号：US9643962B2

  公开（公告）日：2017-05-09